Mr. Speaker, Bill C-56, an act representing assisted human reproduction, provides a legislative balance that protects the health and safety of Canadians and their children and offers new hope for those who wish to conceive a child but have been unable to do so.
These are not easy issues on which to build a legislative framework. There is currently no comprehensive federal or provincial legislative framework governing assisted human reproduction procedures and related research.
The legislation we have before us today is the product of thorough consultation and review on this very sensitive topic. It is based on Canadian values and reflects a consensus on some very complex and very challenging issues.
We are aware Canadians have strong and differing views on the issues centring on assisted human reproduction and this legislation must be reflective of the diversity and requisite sensitivity needed in dealing with this. The legislation also needs to establish clearly defined boundaries between what is acceptable and what is not.
We will not accept the creation of life for reasons other than building a family. Cloning human beings is equally as intolerable as modifying an embryo to suit our personal preferences. We will not put a price tag on sperm, eggs, embryos or the process of pregnancy. These are not goods or services suitable for commercialization.
The proposed act, Bill C-56, addresses the needs of infertile couples who wish to make use of assisted human reproduction process in a safe, regulated environment. Children are indeed a blessing. As a mother of four I can stand before the House and say that it is my proudest moment of anything I will accomplish in life being the mother of four children.
However I am sure we all know couples who have encountered difficulties in building a family. We have seen their frustration as well as their disappointment and it is heart-rending. The truth is approximately one in eight Canadian couples faces the challenge of infertility. A core principle of the proposed legislation is free and informed consent. Any procedure to assist human reproduction as well as AHR related research would require prior written consent of the donors based on the most current information on AHR as to how they would make that informed decision.
Important aspects of Bill C-56 are the provisions to ensure reproductive technologies are safe and healthy options. The proposed legislation will create regulations on the licensing of clinics, the proper handling of eggs, sperm and embryos as well as the number of children that could be born from a single sperm or egg donor.
This is not intended to limit a person's options but rather to ensure the well-being of all involved. Bill C-56 proposes to give children of assisted human reproduction full access to all medical information about their donor parents. As adults they could have access to the information about the identity of their donor parents, provided the donors have also consented to the release of this information.
Bill C-56 proposes to bring Canada up to date with measures taken in other major industrialized countries. We have drawn on the best practices as well as the experience from countries around the world.
Canada's approach is based on Canadian values and speaks to the growing problem of infertility and our increasing reliance on assisted human reproduction.
Bill C-56 would establish the first ever regulatory regime for Canadian fertility clinics. The legislation would prohibit the creation of in vitro embryos for any purpose other than creating a human being or improving assisted human reproduction procedures.
Until now these facilities have operated without regulation. Under the legislation there will be rules on informed consent as well as information in general. Couples who turn to in vitro fertilization or other AHR procedures need reliable information about the technology, the treatment as well as the chances for success.
Another one of the regulatory objectives of Bill C-56 is to ensure that promising research involving in vitro human embryos which are no longer needed for the purposes of reproduction is conducted in a manner consistent with Canadian values.
Research using in vitro embryos may answer many questions about the causes of infertility. It may also advance the development of treatments for spinal cord injuries, diseases like juvenile diabetes, Alzheimer's or cancer.
As we know, embryonic stem cell research is not without controversy. Stem cells are immature precursors of cells that eventually will mature into specialized tissue such as heart, muscle, brain or spinal cord. It does however raise profound concerns about how to balance scientific progress with public safety and how to balance deeply held moral and ethical views that are inherent throughout this entire debate.
The legislation would ensure that promising research related to assisted human reproduction takes place within a regulated environment, an environment where health and safety come first and where Canadian values continue to be respected. The only acceptable source of embryos would be from fully informed couples. It would be up to the couple to choose whether their unused embryo would be discarded or donated to research or to other infertile Canadians.
To monitor and enforce the regulations set forth in this act, the proposed legislation creates the assisted human reproduction agency of Canada. This agency operates as a separate organizational entity from Health Canada and reports to parliament through the Minister of Health.
The legislation we see before us today is a product of extensive transparent review processes. It is the result of more than a decade of consultation, considering the difficult issues that face Canadians. The former Minister of Health took the unprecedented step of first submitting draft legislation to the House of Commons Standing Committee on Health in order to engage in input from all Canadians. These consultations will continue with Bill C-56 as it makes its way through the legislative process.
Bill C-56, an act respecting assisted human reproduction, is meaningful, balanced legislation that is both respectful to Canadian values and to progress enabling research.
This is a beginning, not an ending. I remember very well being a member of the health committee when we looked at xeno transplantation. We had outstanding leading medical ethicists come and talk to us on these very troubling and moral laden questions. I have every confidence that this is a basis upon which we as a government and Canadians can build regarding this very important topic and move forward.